Clarithromycin is an effective immunomodulator in experimental pyelonephritis caused by pan-resistant Klebsiella pneumoniae
Author(s) -
Evangelos J. GiamarellosBourboulis,
Vassiliki Tziortzioti,
Pantelis Koutoukas,
Fotini Baziaka,
Maria Raftogiannis,
Anastasia Antonopoulou,
Theodoros Adamis,
Labros Sabracos,
Helen Giamarellou
Publication year - 2006
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkl084
Subject(s) - amikacin , clarithromycin , spleen , klebsiella pneumoniae , medicine , group b , group a , mesenteric lymph nodes , in vivo , gastroenterology , pharmacology , antibiotics , immunology , microbiology and biotechnology , biology , helicobacter pylori , escherichia coli , biochemistry , gene
To apply clarithromycin as an immunomodulatory treatment in experimental infection caused by pan-resistant Klebsiella pneumoniae.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom